Clicky

CARsgen Therapeutics Holdings Ltd(2171) News

2171 price today by TradingView
Date Title
Aug 29 CARsgen® Announces 2024 Interim Results
Jan 15 CARsgen's CT011 achieves IND clearance from the NMPA for the GPC3-positive stage Ⅲa hepatocellular carcinoma at high risk of recurrence after surgical resection
Dec 4 CARsgen's CT071 Received IND Clearance from the FDA for Treating Relapsed/Refractory Multiple Myeloma or Relapsed/Refractory Primary Plasma Cell Leukemia